Results 211 to 220 of about 484,284 (292)

Supporting Unpaid Caregivers of Persons Living With Dementia: Protocol for a Pilot Feasibility Study to Explore Caregiver Outcomes and Impact of a Co-Designed Simulation-Based Psychoeducation Program in Virtual Reality.

open access: yesJMIR Res Protoc
Chiu M   +13 more
europepmc   +1 more source

Editorial: Caregiving for older adults within community settings. [PDF]

open access: yesFront Public Health
Southerland JL   +3 more
europepmc   +1 more source

Mechanistic Insights Into Photocatalytic Materials for Toxic Pollutants: Environmental Remediation of Personal Care Products

open access: yesAsia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Photocatalytic materials have emerged as promising solutions for environmental applications due to their ability to degrade organic pollutants under sunlight or artificial light. In this review, recent progress on the photocatalytic materials used for the degradation of pharmaceutical personal care products (PPCPs) in environmental ...
Urvashi Sen   +5 more
wiley   +1 more source

Digital support systems to improve child development in Peru: A cluster-randomized controlled open-label trial. [PDF]

open access: yesSci Adv
Fink G   +14 more
europepmc   +1 more source

Caregiver burden and mental health among informal caregivers of older adults in Lebanon. [PDF]

open access: yesDiscov Public Health
Charbaji S   +4 more
europepmc   +1 more source

Improving the outcome of infants born at \u3c30 weeks\u27 gestation - a randomized controlled trial of preventative care at home [PDF]

open access: yes, 2009
Anderson, Peter J   +8 more
core   +1 more source

Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study

open access: yesArthritis &Rheumatology, EarlyView.
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy